Search

everythinglearnresearchcommunity

for

Search:↓

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Calancardin B may help reduce inflammation in immune cells.

Most adverse reactions to the treatment were mild, with nausea being the most common.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Albendazole and praziquantel can cause severe side effects, especially with prolonged use or liver issues.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Dupilumab may cause hair loss, so patients should be monitored.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Upadacitinib effectively treats pyoderma gangrenosum.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.